What's New on the FDA Drugs Site
July 9, 2012
- Drug Firm Annual Registration Status Download File
- Drug Firm Annual Registration Status (updated)
- DIA/FDA: Biosimilars Conference: Guidances, Science, and BsUFA, September 12-13 2012, Washington Marriott Wardman Park, Washington, DC. Meeting information and registration
- National Drug Code Directory (updated)
- Pediatric Exclusivity Statistics (updated)
- Questions and Answers: FDA approves a Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting (ER/LA) Opioid Analgesics
- Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting Opioids (updated)
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
